.Pharmacolibrary.Drugs.ATC.S.S02AA17_1 .Pharmacolibrary.Drugs.ATC.S.S02AA17_1| name: | Fosfomycin_1 |
| ATC code: | S02AA17_1 | route: | intravenous |
| n-compartments | 2 |
Fosfomycin is a broad-spectrum antibiotic, chiefly against Gram-negative bacteria and some Gram-positives. Used orally and intravenously, it is approved for monotherapy of uncomplicated urinary tract infection and, intravenously, for serious infections (off-label in some regions).
Pharmacokinetics of intravenous fosfomycin disodium in healthy adults after single infusion.
Götz, KM, et al., & Lehr, T (2025). Population pharmacokinetics of intravenous fosfomycin: dose optimization for critically ill patients with and without kidney replacement therapy. Antimicrobial agents and chemotherapy 69(6) e0177924–None. DOI:10.1128/aac.01779-24 PUBMED:https://pubmed.ncbi.nlm.nih.gov/40323336
Parker, SL, et al., & Roberts, JA (2015). Population Pharmacokinetics of Fosfomycin in Critically Ill Patients. Antimicrobial agents and chemotherapy 59(10) 6471–6476. DOI:10.1128/AAC.01321-15 PUBMED:https://pubmed.ncbi.nlm.nih.gov/26239990
Hüppe, T, et al., & Kreuer, S (2023). Population pharmacokinetic modeling of multiple-dose intravenous fosfomycin in critically ill patients during continuous venovenous hemodialysis. Scientific reports 13(1) 18132–None. DOI:10.1038/s41598-023-45084-5 PUBMED:https://pubmed.ncbi.nlm.nih.gov/37875513